GP
IMUX icon

GLG Partners’s Immunic IMUX Stock Holding History

GLG Partners’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$65K Buy
+27
New +$59.7K ﹤0.01% 440

Other funds holding IMUX

Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
TP
Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $1.24B AUM 2.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GLG Partners's IMUX Position: Q4 2017 in Review

GLG Partners opened a new position in Immunic (IMUX) in Q4 2017: 27 shares worth $65K. The stake represents ﹤0.01% of the portfolio and ranks #440 among its holdings.

57 funds tracked by Wall St. Rank hold IMUX as of Q4 2017.

  • GLG Partners held 27 shares of Immunic worth $65K as of Q4 2017.
  • Immunic was a new GLG Partners position in Q4 2017.
  • Immunic made up ﹤0.01% of GLG Partners's portfolio in Q4 2017, its #440 holding.
  • 57 funds tracked by Wall St. Rank held Immunic as of Q4 2017.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.